Femasys (FEMY) EBITDA (2020 - 2025)
Femasys' (FEMY) quarterly EBITDA came in at -$3.9 million in Q2 2025, up 14.07% YoY from -$3.4 million in Q2 2024, and up 29.47% on a QoQ basis from -$5.5 million in Q1 2025.
Femasys (FEMY) EBITDA (2020 - 2025) Analysis & Trends
Femasys (FEMY) has 6 years of EBITDA data on file, last reported at -$3.9 million in Q2 2025.
- Quarterly EBITDA rose 14.07% year-over-year to -$3.9 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$19.2 million (down 16.25% YoY) and the FY2025 annual result came in at -$17.6 million, up 1.11% from the prior year.
- EBITDA grew to -$3.9 million in Q2 2025, from -$5.5 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$1.8 million in Q1 2021 to a low of -$5.5 million in Q1 2025.
- A 5-year average of -$3.4 million and a median of -$3.0 million in 2022 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA sank 57.83% — and 2025, when it rose 14.07%.
- Tracing FEMY's EBITDA over 5 years: stood at -$2.4 million in 2021, then slipped by 27.26% to -$3.0 million in 2022, then plunged by 48.3% to -$4.4 million in 2023, then declined by 6.14% to -$4.7 million in 2024, then increased by 18.44% to -$3.9 million in 2025.
- The last three EBITDA figures came in at -$3.9 million (Q2 2025), -$5.5 million (Q1 2025), and -$4.7 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 971.90 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 663.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 11.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 448.71 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 395.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 181.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -31.00 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 217.00 Mn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | -5.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -3.85 Mn |
| Mar 31, 2025 | -5.46 Mn |
| Dec 31, 2024 | -4.72 Mn |
| Sep 30, 2024 | -5.12 Mn |
| Jun 30, 2024 | -4.48 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Dec 31, 2023 | -4.45 Mn |
| Sep 30, 2023 | -4.08 Mn |
| Jun 30, 2023 | -2.94 Mn |
| Mar 31, 2023 | -3.04 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | -3.06 Mn |
| Jun 30, 2022 | -2.66 Mn |
| Mar 31, 2022 | -2.88 Mn |
| Dec 31, 2021 | -2.36 Mn |
| Sep 30, 2021 | -2.25 Mn |
| Jun 30, 2021 | -1.90 Mn |
| Mar 31, 2021 | -1.83 Mn |
| Dec 31, 2020 | -1.66 Mn |
| Sep 30, 2020 | -1.56 Mn |